MCID: URT014
MIFTS: 38

Ureterolithiasis

Categories: Nephrological diseases

Aliases & Classifications for Ureterolithiasis

MalaCards integrated aliases for Ureterolithiasis:

Name: Ureterolithiasis 12 44 15 17 72
Calculus of Ureter 12 33
Ureteric Calculus 12
Ureteral Calculi 72
Ureteric Stone 12

Classifications:



External Ids:

Disease Ontology 12 DOID:14146
ICD9CM 35 592.1
MeSH 44 D053039
NCIt 50 C114696
SNOMED-CT 68 31054009 95573009
ICD10 33 N20.1
UMLS 72 C0041952 C1456865

Summaries for Ureterolithiasis

MalaCards based summary : Ureterolithiasis, also known as calculus of ureter, is related to hydronephrosis and nephrolithiasis, calcium oxalate. An important gene associated with Ureterolithiasis is CHRM3 (Cholinergic Receptor Muscarinic 3), and among its related pathways/superpathways are Salivary secretion and Monoamine GPCRs. The drugs Alfuzosin and Sodium citrate have been mentioned in the context of this disorder. Affiliated tissues include kidney, brain and colon.

Wikipedia : 75 Kidney stone disease, also known as urolithiasis, is when a solid piece of material (kidney stone)... more...

Related Diseases for Ureterolithiasis

Diseases related to Ureterolithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 149)
# Related Disease Score Top Affiliating Genes
1 hydronephrosis 10.6
2 nephrolithiasis, calcium oxalate 10.6
3 ureteral obstruction 10.5
4 pyelonephritis 10.4
5 pyuria 10.3
6 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.3
7 appendicitis 10.3
8 toxic shock syndrome 10.2
9 back pain 10.2
10 acute cystitis 10.2
11 urinary tract obstruction 10.2
12 vesicoureteral reflux 1 10.1
13 hyperparathyroidism 10.1
14 endometriosis 10.1
15 anuria 10.1
16 kidney disease 10.1
17 acute pyelonephritis 10.1
18 diverticulitis 10.1
19 mycobacterium tuberculosis 1 10.1
20 peritonitis 10.1
21 male infertility 10.1
22 impotence 10.1
23 constipation 10.1
24 gastroenteritis 10.1
25 prostatic adenoma 10.1
26 triiodothyronine receptor auxiliary protein 10.0
27 prostatic hyperplasia, benign 10.0
28 leptin deficiency or dysfunction 10.0
29 pain agnosia 10.0
30 prostatic hypertrophy 10.0
31 visual epilepsy 10.0
32 bacteriuria 10.0
33 ureteral disease 10.0
34 squamous cell carcinoma 10.0
35 rectum cancer 10.0
36 chronic kidney disease 10.0
37 pure autonomic failure 10.0
38 seizure disorder 10.0
39 intussusception 10.0
40 schistosoma mansoni infection, susceptibility/ 10.0
41 ureterocele 10.0
42 cystinuria 10.0
43 body mass index quantitative trait locus 1 10.0
44 graft-versus-host disease 10.0
45 adenine phosphoribosyltransferase deficiency 10.0
46 hydrops, lactic acidosis, and sideroblastic anemia 10.0
47 metabolic acidosis 10.0
48 atrial fibrillation 10.0
49 xanthogranulomatous pyelonephritis 10.0
50 squamous cell papilloma 10.0

Comorbidity relations with Ureterolithiasis via Phenotypic Disease Network (PDN): (show all 12)


Acute Cystitis Bladder Neck Obstruction
Hydronephrosis Nephrolithiasis, Uric Acid
Nephrolithiasis, X-Linked Recessive, with Renal Failure Paralytic Ileus
Prostate Cancer Prostatic Hypertrophy
Pyelonephritis Urethral Calculus
Urethral Stricture Urinary Tract Obstruction

Graphical network of the top 20 diseases related to Ureterolithiasis:



Diseases related to Ureterolithiasis

Symptoms & Phenotypes for Ureterolithiasis

Drugs & Therapeutics for Ureterolithiasis

Drugs for Ureterolithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 86)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Alfuzosin Approved, Investigational Phase 4 81403-80-7 2092
2
Sodium citrate Approved, Investigational Phase 4 68-04-2
3
Acetaminophen Approved Phase 4 103-90-2 1983
4
Nefopam Approved, Investigational Phase 4 13669-70-0
5
Morphine Approved, Investigational Phase 4 57-27-2 5288826
6
Ketoprofen Approved, Vet_approved Phase 4 22071-15-4 3825
7
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
8
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
9
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
10
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
11
Tamsulosin Approved, Investigational Phase 4 106133-20-4 129211
12
Silodosin Approved Phase 4 160970-54-7
13
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
14 Adrenergic alpha-1 Receptor Antagonists Phase 4
15 Adrenergic alpha-Antagonists Phase 4
16 Adrenergic Antagonists Phase 4
17 Neurotransmitter Agents Phase 4
18 Adrenergic Agents Phase 4
19 Sildenafil Citrate Phase 4 171599-83-0
20 Citrate Phase 4
21 Phosphodiesterase Inhibitors Phase 4
22 Phosphodiesterase 5 Inhibitors Phase 4
23 Vasodilator Agents Phase 4
24 Antipyretics Phase 4
25 Pharmaceutical Solutions Phase 4
26 Antibiotics, Antitubercular Phase 4
27 Anti-Infective Agents Phase 4
28 Anti-Bacterial Agents Phase 4
29 Narcotics Phase 4
30 Central Nervous System Depressants Phase 4
31 Analgesics, Opioid Phase 4
32 Ketorolac Tromethamine Phase 4
33 Cytochrome P-450 Enzyme Inhibitors Phase 4
34 Topoisomerase Inhibitors Phase 4
35 Cytochrome P-450 CYP1A2 Inhibitors Phase 4
36
Nifedipine Approved Phase 3 21829-25-4 4485
37
Prazosin Approved Phase 3 19216-56-9 4893
38
Doxazosin Approved Phase 3 74191-85-8 3157
39
Aceclofenac Approved, Investigational Phase 3 89796-99-6
40
Tramadol Approved, Investigational Phase 3 27203-92-5 33741
41
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
42 Naftopidil Investigational Phase 3 57149-07-2
43 Tocolytic Agents Phase 3
44 Hormones Phase 3
45 Antihypertensive Agents Phase 3
46 Platelet Aggregation Inhibitors Phase 3
47 Calcium, Dietary Phase 3
48 calcium channel blockers Phase 3
49
Mirabegron Approved Phase 2 223673-61-8 9865528
50 Adrenergic Agonists Phase 2

Interventional clinical trials:

(show top 50) (show all 72)
# Name Status NCT ID Phase Drugs
1 Efficacy of Tamsulosin OCAS in the Conjunctive Medical Treatment of Distal Ureteral Stones.A Randomized, Double-blind, Placebo-controlled Study Unknown status NCT01167062 Phase 4 Tamsulosin Hydrochloride OCAS 0.4 mg
2 The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study Unknown status NCT00489112 Phase 4 Alfuzocine XL 10 mg once a day
3 The Effectiveness and Safety of Naftopidil 75mg for Improving Clearance of Ureteral and Renal Stones After Shockwave Lithotripsy: Prospective Randomized Controlled Study Unknown status NCT02011737 Phase 4 naftopidil 75mg
4 A Comparison Between Flexible Ureteroscopy, Semirigid Ureteroscopy and Extracorporeal Shockwaves Lithotripsy (SWL) in The Management of Proximal Ureteric Stones. A Randomized Controlled Trial Unknown status NCT02469766 Phase 4
5 Role of Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) in Management of Distal Ureteral Stone Unknown status NCT02519153 Phase 4 Sildenafil
6 The Efficacy of Alpha-blockers for Expulsion of Distal Ureteral Stones Unknown status NCT00451061 Phase 4 Alfuzosin;Tamsulosin
7 Interest of Néfopam in the Treatment of Pain During the Intense Ureteral Calculi Uncomplicated in Adults in Emergencies Unit. Completed NCT00639574 Phase 4 Néfopam
8 A 4-week, Double-blind, Randomized, Comparative and Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones. Completed NCT01533389 Phase 4 Silodosin;Placebo
9 Study of Tamsulosin for Urolithiasis in the Emergency Department Completed NCT00382265 Phase 4 tamsulosin
10 A Double Blind, Multi-arm Randomized Control Trial, for Efficacy of Intramuscular Diclofenac Versus Intravenous Morphine Versus Intravenous Paracetamol, in Renal Colic Emergency Department Pain Management Completed NCT02187614 Phase 4 Diclofenac;Morphine;Paracetamol;Placebos
11 Study of Ketorolac Versus Opioid for Pain After Endoscopy (SKOPE): A Double-blinded Randomized Control Trial Comparing Outpatient Analgesic Efficacy of NSAIDs and Opioids in Patients Undergoing Ureteroscopy for Kidney Stones Recruiting NCT03888144 Phase 4 Oxycodone;Ketorolac
12 Efectividad de la Tamsulosina Como Tratamiento Adyuvante Previo a Ureterolitotomia Endoscopica Recruiting NCT03614052 Phase 4 Tamsulosin Hydrochloride 0.4 milligrams;Placebo Oral Tablet
13 A Multicenter Randomized Controlled Trial Assessing the Efficacy of Antimicrobial Prophylaxis for Extracorporeal Shock Wave Lithotripsy on Reducing Urinary Tract Infection Recruiting NCT03692715 Phase 4 Ciprofloxacin;Placebo
14 Comparison of Silodosin vs. Tamsulosin on Spontaneous Passage of Acutely Obstructing Ureteral Calculi in Medical Expulsive Therapy Terminated NCT02369744 Phase 4 Silodosin;Tamsulosin
15 Celecoxib in the Management of Acute Renal Colic Withdrawn NCT00304317 Phase 4 celecoxib
16 Evaluation of Alfuzosin as Medical Expulsion Therapy for Ureteral Stones Unknown status NCT00713739 Phase 3 Alfuzosin;nifedipine;doxazosin;prazosin
17 Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi Completed NCT00177086 Phase 3
18 Medical Expulsive Therapy for Ureter Stone Using Naftopidil: Multicenter, Randomized, Double-blind, Placebo Controlled Study Completed NCT01952314 Phase 3 Naftopidil 75mg;Placebo for Naftopidil;Standard treatment
19 Phase II Study Comparing Two Groups of Patients Undergoing ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin Unknown status NCT00478998 Phase 2 Tamsulosin
20 Prospective Randomized Placebo Controlled Blinded Study to Evaluate the Efficacy of Alfuzosin (Alpha Blocker) on the Success Rates Following SWL. Unknown status NCT00409227 Phase 2 Alpha blocker-alfuzosin;placebo
21 A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage Completed NCT01144949 Phase 2 silodosin;placebo
22 A Double Blind Placebo Control Trial of Mirabegron for Medical Expulsive Therapy and to Manage Stent Pain for Ureteral Stones(Protocol # 01-16-20-02) Recruiting NCT02744430 Phase 2 Mirabegron
23 URIPRENE: Feasibility Study to Evaluate the Preliminary Safety and Effectiveness of the Uriprene Stent Following Uncomplicated Ureteroscopy Completed NCT02032316 Phase 1
24 The Use of Tamsulosin in Treatment of (10-15 mm) Lower Ureteric Stones in Adults With Non-emergent Symptoms: A Prospective Randomized Study Unknown status NCT03274700 Early Phase 1 Tamsulosin.;Placebo.
25 Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During Unknown status NCT02279927
26 Shockwave Lithotripsy (SWL) Under Regular General Anesthesia and Under General Anesthesia Using Bronchial Blocker. Unknown status NCT01008267
27 The Impact of Silent Ureteral Stone on Renal Function and Kidney Anatomy: a Prospective Analysis Unknown status NCT01884870
28 Comparative Study in Patients With Lower Ureteral Stones Treated With 10 MG Alfuzosin,10 MG Alfuzosin With Rowatinex, and Rowatinex Alone Unknown status NCT00397397
29 Intraureteral of Alkalinized Lidocaine as Novel Approach to Post-Ureteroscopy Pain: Double-blind Prospective Randomized Controlled Trial Unknown status NCT01450566 Lidocaine;Saline
30 Staged Ureteroscopy After Initial Urinary Drainage Versus Direct Ureteroscopy in the Treatment of Pediatric Obstructive Calcular Anuria Unknown status NCT02139059
31 Ultrasound Non-contrast Computed Tomography Real-time Fusion for Urinary Stones Follow up Unknown status NCT02539004
32 Impact of Low Dose Fluoroscopy in Ureteroscopy Unknown status NCT02704949
33 The Alternating Bidirectional Versus The Standard Approach During Shock Wave Lithotripsy For Renal And Upper Lumbar Ureteric Stones. A Randomized Clinical Trial Unknown status NCT03243682
34 The Influence of Super-Mini Percutaneous Nephrolithotomy on Renal Pelvic Pressure In Vivo Unknown status NCT02760134
35 The Use of Non-contrast Helical Computerized Tomogram in Predicting Treatment Outcome of Upper Ureteric Stone by Extracorporeal Shock Wave Lithotripsy Using the Sonolith 4000+ Lithotripter Completed NCT00517205
36 Is Prophylactic Antibiotics Necessary In Otherwise Healthy Adult Patients Undergoing Ureteroscopic Procedures for Ureteral Stones? Completed NCT02635490
37 Comparing Uretersocopy With Versus Without Use of Guide-wire in Treatment of Ureteral Stone Completed NCT03726502
38 The Role of Flexible Cystoscopy in Laparoscopic Stone Surgery: a Single Surgeon Experience Completed NCT01277198
39 Evaluation of Ureteral Length Measurement by Computed Tomography (CT) to Actual Ureteral Length Measured by Ureteral Catheterization Completed NCT01542593
40 Medical Expulsive Therapy of Single Distal Ureteral Stones. A Randomised, Double-blind and Placebo-controlled Study Completed NCT00831701 Tamsulosin;Placebo
41 Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis Completed NCT00762424 Flowmax;placebo
42 Comparative Study of Extracorporeal Shock Wave Lithotripsy and Ureteroscopy in Management of Upper Third Ureteral Calculi Completed NCT03559738
43 The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients Completed NCT00600405 tamsulosin;Standard therapy with ibuprofen and oxycodone.
44 Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage in Children With Obstructive Anuria and Acute Renal Failure Due to Ureteral Calculi: a Prospective, Randomized Study Completed NCT02055430
45 Use of the PercSys MicroStent Device to Alleviate Ureteral Stone Symptoms and Hydronephrosis Completed NCT01637519
46 Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach Completed NCT01792765
47 The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients Completed NCT00448123 Tamsulosin;Placebo
48 Determine the Effectiveness of Convective Uses of Basket Wires for the Maintenance of Stone and Pneumatic Probe in the Treatment of Ureteral Stones Completed NCT03980444
49 The Usefulness of Flexible Cystoscopy for Preventing Double-J Stent Malposition After Laparoscopic Ureterolithotomy Completed NCT03150446
50 Brushite Stones: A Registry and Database of Clinical and Laboratory Findings Completed NCT00169663

Search NIH Clinical Center for Ureterolithiasis

Inferred drug relations via UMLS 72 / NDF-RT 51 :


Doxazosin
Nifedipine
Tamsulosin
Terazosin

Cochrane evidence based reviews: ureterolithiasis

Genetic Tests for Ureterolithiasis

Anatomical Context for Ureterolithiasis

MalaCards organs/tissues related to Ureterolithiasis:

41
Kidney, Brain, Colon, Liver, Ovary, Testes, Adrenal Gland

Publications for Ureterolithiasis

Articles related to Ureterolithiasis:

(show top 50) (show all 320)
# Title Authors PMID Year
1
Dynamic thiol/disulfide homeostasis as a novel indicator of oxidative stress in patients with urolithiasis. 38
31294135 2019
2
Identification of ureteral stones at reduced radiation exposure: a pilot study comparing conventional versus digital low-dosage linear slot scanning (Lodox®) radiography. 38
31165230 2019
3
Limited sensitivity and size over measurements of ultrasound affect medical decisions for ureteral stone compared to non-contrasted computed tomography. 38
30109485 2019
4
Medical and Interventional Management of Upper Urinary Tract Uroliths. 38
30736892 2019
5
[Abdominal ultrasound in emergency and critical care medicine]. 38
30840096 2019
6
Unconventional natural gas development and hospitalizations: evidence from Pennsylvania, United States, 2003-2014. 38
30677623 2019
7
Clinical Effects of Polymyxin B Hemoperfusion in Patients With Septic Shock Caused by Urinary Tract Infection. 38
30209889 2019
8
Re: Minimizing the Cost of Treating Asymptomatic Ureterolithiasis. 38
30577359 2019
9
Ureterolithiasis and the quest for rational use of diagnostic imaging methods. 38
30559568 2018
10
Use of a subcutaneous ureteral bypass device for treatment of benign ureteral obstruction in cats: 174 ureters in 134 cats (2009-2015). 38
30398425 2018
11
Bilateral ureterolithiasis: A true positive and false negative PoCUS exam in a patient with renal colic. 38
29606152 2018
12
Narcotic Pain Control for Ureterolithiasis Is Associated With Unnecessary Repeat Imaging in the Emergency Department. 38
30358635 2018
13
Acute synchronous appendicitis and obstructing ureterolithiasis. 38
30108673 2018
14
Perinephric Fat Stranding Is Associated with Elevated Creatinine Among Patients with Acutely Obstructing Ureterolithiasis. 38
29943669 2018
15
CONTACT ULTRASOUND LITHOTRIPSY DURING URETEROLITHIASIS THERAPY. AN ANALYSIS OF LATE POSTOPERATIVE COMPLICATIONS. 38
30358535 2018
16
Epidemiological and imaging features that can affect the detection of ureterolithiasis on ultrasound. 38
30369654 2018
17
Does fasting in Ramadan increase the risk of developing urinary stones? 38
29738008 2018
18
[Results of laparoscopic ureterolithotomy depending on the type of laparoscopic approach and location of the stone]. 38
29634145 2018
19
Outcome of ureteral stent placement for treatment of benign ureteral obstruction in dogs: 44 cases (2010-2013). 38
29504861 2018
20
Predictive value of secondary signs of obstruction in follow-up computed tomography of ureteral stones: a study with dynamic computed tomography. 38
29037128 2018
21
Differential diagnoses of magnetic resonance imaging for suspected acute appendicitis in pregnant patients. 38
29290892 2018
22
Treatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat. 38
30568915 2018
23
An Accurate Diagnostic Pathway Helps to Correctly Distinguish Between the Possible Causes of Acute Scrotum. 38
29468000 2018
24
Influence of acetylsalicylic acid and low-molecular weight heparins on the formation of renal hematoma after shock wave lithotripsy. 38
28702844 2017
25
[Biomarkers of renal injury in contact ureteral lithotripsy]. 38
29135147 2017
26
Emergency Ureteral Stone Treatment Score Predicts Outcomes of Ureteroscopic Intervention in Acute Obstructive Uropathy Secondary to Urolithiasis. 38
28637368 2017
27
Comparison between double-pigtail ureteral stents and ureteral bypass devices for treatment of ureterolithiasis in cats. 38
28763282 2017
28
Different Approaches to Detect "Nanobacteria" in Patients with Kidney Stones: an Infectious Cause or a Subset of Life? 38
28853105 2017
29
Medical expulsive therapy use in emergency department patients diagnosed with ureteral stones. 38
28291706 2017
30
Case control study: hyperbaric oxygen treatment of mild traumatic brain injury persistent post-concussion syndrome and post-traumatic stress disorder. 38
29152209 2017
31
[Questions of terminology, systematization and grading of complications of contact ureteral lithotripsy]. 38
28845938 2017
32
Imaging of Acute Pelvic Pain in Girls: Ovarian Torsion and Beyond☆. 38
28185689 2017
33
A Comparison of Urolithiasis in the Presence and Absence of Microscopic Hematuria in the Emergency Department. 38
28611901 2017
34
Perioperative Occlusion of a Subcutaneous Ureteral Bypass Secondary to a Severe Pyonephrosis in a Birman Cat. 38
28992905 2017
35
Ureterolithiasis: Management in an environment with limited facilities. 38
28513524 2017
36
Medical Expulsive Therapy for Ureterolithiasis: The EAU Recommendations in 2016. 38
27506951 2017
37
Can Doppler ultrasonography twinkling artifact be used as an alternative imaging modality to non-contrast-enhanced computed tomography in patients with ureteral stones? A prospective clinical study. 38
27170278 2017
38
Glomerular filtration rate determination by computed tomography in two pet rabbits with renal disease. 38
28263109 2017
39
Comparison of prone vs. supine unenhanced CT imaging in patients with clinically suspected ureterolithiasis. 38
27670877 2017
40
Paediatric ureterolithotripsy: Tips and tricks - Experience at a single center. 38
29487266 2017
41
Spontaneous proximal ureteric rupture secondary to ureterolithiasis. 38
28069871 2017
42
The Diagnosis and Management of Patients with Renal Colic across a Sample of US Hospitals: High CT Utilization Despite Low Rates of Admission and Inpatient Urologic Intervention. 38
28046001 2017
43
[Extracorporeal and contact lithotripsy for large ureteral stones]. 38
28248059 2016
44
Clinical relevance of seasonal changes in the prevalence of ureterolithiasis in the diagnosis of renal colic. 38
27314408 2016
45
Sex-related Differences in Emergency Department Renal Colic Management: Females Have Fewer Computed Tomography Scans but Similar Outcomes. 38
27357754 2016
46
Is Hydronephrosis on Ultrasound Predictive of Ureterolithiasis in Patients with Renal Colic? 38
27154825 2016
47
Can ureteral stones cause pain without causing hydronephrosis? 38
26685981 2016
48
Procalcitonin is a strong predictor of urine culture results in patients with obstructing ureteral stones: A prospective, pilot study. 38
27453647 2016
49
Beyond ureterolithiasis: gamut of abnormalities affecting the ureter. 38
27317212 2016
50
[Subcutaneous ureteral bypass devices as a treatment option for bilateral ureteral obstruction in a cat with ureterolithiasis]. 38
26898228 2016

Variations for Ureterolithiasis

Expression for Ureterolithiasis

Search GEO for disease gene expression data for Ureterolithiasis.

Pathways for Ureterolithiasis

Pathways related to Ureterolithiasis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.37 CHRM3 ADRA1D
2
Show member pathways
11 CHRM3 ADRA1D
3 10.63 CHRM3 ADRA1D

GO Terms for Ureterolithiasis

Sources for Ureterolithiasis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....